Three different doses of Niktimvo all had high rates of response among patients with recurrent or refractory ...

The future of pain medicine is characterized by treatments and technologies — including virtual reality, AI, wearable tech ...

Independence Blue Cross has increased local provider options by 47% since 2022, and now offers additional mental health and ...

Results of a survey show that Black/Indigenous/People of Color or Hispanic patients with Crohn's disease or ulcerative ...

Whether Express Scripts wins its unique defamation lawsuit will depend on whether the PBM can prove the FTC made false ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

When CMS begins negotiations for physician-administered drugs under the Inflation Reduction Act, providers, including those ...

The FDA rejected an application to approve MDMA, also known as ecstasy, as a treatment for PTSD. Next up among the ...

The FDA has approved Lilly’s Ebglyss (lebrikizumab-lbkz) for the treatment of moderate to severe atopic dermatitis in adults ...

Express Scripts alleges in its suit that the FTC followed “prejudice and politics, not evidence or sound economics,” and that ...

Patients with vitiligo may significantly improve the effectiveness of a commonly used light therapy — by nearly twofold— by ...

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.